Table 3. Final pathology.

Variable	Period 1: 2006-2010 (n=61)	Period 2: 2011-2013 (n=62)	p-value
Histology			0.37
Endometrioid adenocarcinoma	50 (82.0)	57 (91.9)
Mixed adenocarcinoma	4 (6.6)	1 (1.6)
Type 2	4 (6.6)	2 (3.2)
No residual tumour	3 (4.9)	2 (3.2)
Histological grade			0.22
1	40/54 (74.1)	44/58 (75.9)
2	11/54 (20.4)	13/58 (22.4)
3	3/54 (5.5)	1/58 (1.7)
Lymphovascular space invasion	16 (26.2)	12 (19.4)	0.36
Positive pelvic nodes	5/54 (9.3)	2/12 (16.7)	0.60
Risk for recurrence			0.71
Low-risk	32 (52.5)	37 (59.7)
Intermediate-risk	10 (16.4)	8 (12.9)
High-risk or FIGO stage >I*	19 (31.1)	17 (27.4)

Values are presented as number (%).

^*It indicates understaging.

FIGO, International Federation of Gynecology and Obstetrics.